You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》上證深成窄幅走個別 康希諾生物高開6.8%
人民銀行行長易綱在二十國集團(G20)會議上發言時表示,內地通脹總體溫和,貨幣政策靈活精準、合理適度,服務實體經濟的質量和效率不斷提升,並將保持穩健的貨幣政策靈活適度,加大跨週期調節力度,推動經濟高質量發展。 內地昨日(20日)新增本土確診病例71例。人民銀行公佈,一年期及五年期LPR維持不變女利率持平於3.7%及4.6%,今日(21日)進行100億元人民幣(下同)7天期逆回購操作,單日零投放零回籠。人民幣兌美元中間價今下調58點。地緣政治局勢仍然緊張,上證深成創板窄幅走個別。 上證綜指低開2點或0.07%,開報3,488點;深證成指高開5點或0.04%,開報13,464點;滬深300低開5點或0.1%,開報4,646;創業板指高開3點或0.1%,報2,830點。 中資金融股偏軟,工行(601398.SH)及建行(601939.SH)分別低開0.2%及0.3%。中移動(600941.SH)微微高開0.3%。 航空股回軟,國航(601111.SH)及南航(600029.SH)分別低開1%及0.1%。內地將2022年暫停航空運輸企業預繳增值稅一年。 康希諾生物(688185.SH)新冠疫苗克威莎獲批序貫加強免疫,股價高開6.8%。 比亞迪(002594.SZ)元PLUS訂單量突破兩萬臺,澳洲正式預售,該股股價今早開市跌0.8%。 寧德時代(300750.SZ)開市微跌0.2%。(ta/s) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account